details

Peer companies

;

Share Market News

The revenue for the March 2019 quarter is pegged at Rs. 115.93 millions, about 7.15% up against Rs. 108.19 millions recorded during the year-ago period.The Total Profit for the quarter ended March 2019 of Rs. 3.12 millions grew from Rs.-6.18 millionsOperating profit surged to 23.33 millions from the corresponding previous quarter of 15.72 millions. (Rs. in Million) Quarter ended Year to Date Year ended 201903 201803 % Var 201903 201803 % Var 201803 201703 % Var Sales 115.93 108.19 7.15 462.09 416.37 10.98 410.34 375.64 9.24 Other Income 0.67 0.87 -22.99 2.86 5.38 -46.84 4.81 3.27 47.09 PBIDT 23.33 15.72 48.41 88.64 55.93 58.48 51.29 34.12 50.32 Interest 11.47 13.14 -12.71 49.02 57.99 -15.47 58.99 64.63 -8.73 PBDT 11.86 2.58 359.69 70.99 15.02 372.64 9.37 -30.51 -130.71 Depreciation 8.75 8.84 -1.02 35.33 36.90 -4.25 36.42 36.07 0.97 PBT 3.11 -6.26 -149.68 35.66 -21.88 -262.98 -27.05 -66.58 -59.37 TAX -0.01 0.08 -112.50 0.03 0.08 -62.50 -0.08 -0.27 -70.37 Deferred Tax -0.01 0.08 -112.50 -0.01 0.08 -112.50 -0.08 -0.27 -70.37 PAT 3.12 -6.18 -150.49 35.63 -21.80 -263.44 -26.97 -66.31 -59.33 Equity 48.02 48.02 0.00 48.02 48.02 0.00 48.02 48.02 0.00 PBIDTM(%) 20.12 14.53 38.50 19.18 13.43 42.80 12.50 9.08 37.58

The Revenue for the quarter ended  September 2018 of Rs. 117.50 millions grew by 20.54 % from Rs. 97.48 millions.The Total Profit for the quarter ended September 2018 of Rs. 3.30 millions grew from Rs.-9.70 millionsOperating profit surged to 24.86 millions from the corresponding previous quarter of 15.13 millions. (Rs. in Million) Quarter ended Year to Date Year ended 201809 201709 % Var 201809 201709 % Var 201803 201703 % Var Sales 117.50 97.48 20.54 224.89 202.43 11.10 410.34 375.64 9.24 Other Income 0.30 1.44 -79.17 0.94 3.74 -74.87 4.81 3.27 47.09 PBIDT 24.86 15.13 64.31 39.64 26.77 48.08 51.29 34.12 50.32 Interest 12.77 15.07 -15.26 25.76 30.26 -14.87 58.99 64.63 -8.73 PBDT 12.09 0.06 20050.00 45.25 -3.49 -1396.56 9.37 -30.51 -130.71 Depreciation 8.79 9.76 -9.94 17.91 18.95 -5.49 36.42 36.07 0.97 PBT 3.30 -9.70 -134.02 27.34 -22.44 -221.84 -27.05 -66.58 -59.37 TAX 0.00 0.00 0.00 0.04 0.00 0.00 -0.08 -0.27 -70.37 Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.08 -0.27 -70.37 PAT 3.30 -9.70 -134.02 27.30 -22.44 -221.66 -26.97 -66.31 -59.33 Equity 48.02 48.02 0.00 48.02 48.02 0.00 48.02 48.02 0.00 PBIDTM(%) 21.16 15.52 36.31 17.63 13.22 33.29 12.50 9.08 37.58

The Revenue for the quarter ended  March 2018 of Rs. 108.19 millions grew by 6.13 % from Rs. 101.94 millions.The Net Loss for the quarter ended March 2018 is Rs. -6.18 millions as compared to Net Loss of Rs. -12.27 millions of corresponding quarter ended March 2017Operating profit for the quarter ended March 2018 rose to 15.72 millions as compared to 13.61 millions of corresponding quarter ended March 2017. (Rs. in Million) Quarter ended Year to Date Year ended 201803 201703 % Var 201803 201703 % Var 201703 201603 % Var Sales 108.19 101.94 6.13 422.64 390.99 8.09 364.16 335.31 8.60 Other Income 0.87 0.99 -12.12 4.82 3.27 47.40 0.00 0.00 0.00 PBIDT 15.72 13.61 15.50 61.74 48.65 26.91 52.12 31.63 64.78 Interest 13.14 16.35 -19.63 58.99 64.63 -8.73 64.63 60.99 5.97 PBDT 2.58 -2.74 -194.16 19.83 -15.98 -224.09 -12.51 -29.36 -57.39 Depreciation 8.84 9.53 -7.24 37.44 38.04 -1.58 37.88 39.44 -3.96 PBT -6.26 -12.27 -48.98 -17.61 -54.03 -67.41 -50.39 -68.80 -26.76 TAX 0.08 0.00 0.00 0.08 -0.28 -128.57 0.00 -11.95 -100.00 Deferred Tax 0.08 0.00 0.00 0.08 -0.28 -128.57 0.00 0.00 0.00 PAT -6.18 -12.27 -49.63 -17.53 -53.76 -67.39 -50.39 -56.85 -11.36 Equity 0.00 48.02 0.00 48.02 48.02 0.00 48.02 48.02 0.00 PBIDTM(%) 14.53 13.35 8.83 14.61 12.44 17.40 14.31 9.43 51.73

The December 2017 quarter revenue stood at Rs. 105.75 millions, up 18.53% as compared to Rs. 89.22 millions during the corresponding quarter last year.The Total Profit for the quarter ended December 2017 of Rs. 6.82 millions grew from Rs.-17.51 millionsOP of the company witnessed a marginal growth to 13.44 millions from 7.48 millions in the same quarter last year. (Rs. in Million) Quarter ended Year to Date Year ended 201712 201612 % Var 201712 201612 % Var 201703 201603 % Var Sales 105.75 89.22 18.53 314.45 289.05 8.79 364.16 335.31 8.60 Other Income 0.77 0.41 87.80 3.95 2.28 73.25 0.00 0.00 0.00 PBIDT 13.44 7.48 79.68 46.02 35.04 31.34 52.12 31.63 64.78 Interest 14.59 15.89 -8.18 45.85 48.28 -5.03 64.63 60.99 5.97 PBDT 15.93 -8.41 -289.42 17.25 -13.24 -230.29 -12.51 -29.36 -57.39 Depreciation 9.11 9.10 0.11 28.60 28.51 0.32 37.88 39.44 -3.96 PBT 6.82 -17.51 -138.95 -11.35 -41.76 -72.82 -50.39 -68.80 -26.76 TAX 0.00 0.00 0.00 0.00 -0.28 0.00 0.00 -11.95 -100.00 Deferred Tax 0.00 0.00 0.00 0.00 -0.28 0.00 0.00 0.00 0.00 PAT 6.82 -17.51 -138.95 -11.35 -41.49 -72.64 -50.39 -56.85 -11.36 Equity 48.02 48.02 0.00 48.02 48.02 0.00 48.02 48.02 0.00 PBIDTM(%) 12.71 8.38 51.59 14.64 12.12 20.73 14.31 9.43 51.73

National Oxygen has submitted a copy of the Scrutinizers Report for Results of Postal Ballot pursuant to Clause 44.The above information is a part of company’s filings submitted to BSE.

National Oxygen has submitted a copy of the Scrutinizers Report for Results of Postal Ballot pursuant to Clause 30.The above information is a part of company’s filings submitted to BSE.

National Oxygen has informed about the Standalone Financial Results & a copy of the Limited Review Report for the period ended June 30, 2015.The above information is a part of company’s filings submitted to BSE.

National Oxygen has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.The above information is a part of company’s filings submitted to BSE.

National Oxygen has informed that the board of directors of the company at its meeting held on August 17, 2012, has approved the allotment of 16,85,721 equity shares of Rs.10 each, on rights basis, for cash at a premium of Rs 50 (Issue price of Rs. 50) per equity share aggregating to Rs. 842.86 lakhs finalized as per the terms and conditions of the letter of offer dated June 30, 2012 and as per the basis of allotment approved by stock exchange and such shares shall rank pari passu in all respects with the existing equity shares of the company.The above information is a part of company's filings submitted to BSE.

National Oxygen has informed that the board of directors of the company at its meeting held on June 14, 2012, has approved the final letter of offer for the purpose of rights issue and authorization was given to the board of directors for opening of bank account for rights issue, to decide the opening and closing of the rights issue and signing of the listing application.Further, 20 fixed the price at Rs. 50 (Face value Rs. 10 and Premium at Rs. 40) for issue of 18,69,930 number of equity shares on rights issue in the ratio of 3:5 i.e. three equity shares for every five equity shares held.The above information is a part of company's filings submitted to BSE.

National Oxygen has informed that the board of directors of the company at its meeting held on May 30, 2012, has transacted that the board meeting is adjourned to June 06, 2012 for consideration of items of business due to non-receipt of statutory approvals relating to the approval of letter of offer for the purpose of Rights issue, fixation of the record date for the purpose of rights issue and formation of rights issue committee to undertake the rights issue activities.The above information is part of company’s filing submitted to the BSE.